Morgan Stanley’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.1M | Sell |
2,242,243
-121,859
| -5% | -$2.4M | ﹤0.01% | 2253 |
|
|
2025
Q4 | $44.8M | Buy |
2,364,102
+310,183
| +15% | +$5.75M | ﹤0.01% | 2190 |
|
|
2025
Q3 | $38.3M | Sell |
2,053,919
-46,725
| -2% | -$873K | ﹤0.01% | 2246 |
|
|
2025
Q2 | $38.7M | Buy |
2,100,644
+266,231
| +15% | +$4.72M | ﹤0.01% | 2156 |
|
|
2025
Q1 | $32M | Sell |
1,834,413
-267,552
| -13% | -$4.51M | ﹤0.01% | 2217 |
|
|
2024
Q4 | $36.4M | Sell |
2,101,965
-323,337
| -13% | -$5.9M | ﹤0.01% | 2132 |
|
|
2024
Q3 | $45.1M | Buy |
2,425,302
+615,327
| +34% | +$10.4M | ﹤0.01% | 1924 |
|
|
2024
Q2 | $27.9M | Sell |
1,809,975
-143,263
| -7% | -$2.05M | ﹤0.01% | 2309 |
|
|
2024
Q1 | $28.8M | Sell |
1,953,238
-2,104,470
| -52% | -$29.1M | ﹤0.01% | 2291 |
|
|
2023
Q4 | $57.9M | Buy |
4,057,708
+2,295,756
| +130% | +$32.6M | ﹤0.01% | 2288 |
|
|
2023
Q3 | $24.6M | Buy |
1,761,952
+493,524
| +39% | +$6.31M | ﹤0.01% | 2238 |
|
|
2023
Q2 | $14.9M | Sell |
1,268,428
-186,048
| -13% | -$2.12M | ﹤0.01% | 2783 |
|
|
2023
Q1 | $16.7M | Sell |
1,454,476
-371,760
| -20% | -$4.6M | ﹤0.01% | 2615 |
|
|
2022
Q4 | $22.7M | Sell |
1,826,236
-242,708
| -12% | -$3.09M | ﹤0.01% | 2209 |
|
|
2022
Q3 | $27.1M | Buy |
2,068,944
+169,422
| +9% | +$2.5M | ﹤0.01% | 1872 |
|
|
2022
Q2 | $26.5M | Buy |
1,899,522
+1,177,314
| +163% | +$15.7M | ﹤0.01% | 1981 |
|
|
2022
Q1 | $10.8M | Sell |
722,208
-159,085
| -18% | -$2.18M | ﹤0.01% | 2823 |
|
|
2021
Q4 | $11.9M | Buy |
881,293
+100,150
| +13% | +$1.42M | ﹤0.01% | 2751 |
|
|
2021
Q3 | $11.5M | Buy |
781,143
+137,024
| +21% | +$2.31M | ﹤0.01% | 2731 |
|
|
2021
Q2 | $11.7M | Sell |
644,119
-30,712
| -5% | -$547K | ﹤0.01% | 2801 |
|
|
2021
Q1 | $11.7M | Sell |
674,831
-539,962
| -44% | -$9.5M | ﹤0.01% | 2494 |
|
|
2020
Q4 | $21.1M | Buy |
1,214,793
+990,436
| +441% | +$15.8M | ﹤0.01% | 1765 |
|
|
2020
Q3 | $3.09M | Sell |
224,357
-246,452
| -52% | -$3.62M | ﹤0.01% | 3223 |
|
|
2020
Q2 | $6.79M | Buy |
470,809
+153,849
| +49% | +$2.02M | ﹤0.01% | 2345 |
|
|
2020
Q1 | $3.46M | Sell |
316,960
-334,055
| -51% | -$6.16M | ﹤0.01% | 2814 |
|
|
2019
Q4 | $13.9M | Buy |
651,015
+293,488
| +82% | +$6.57M | ﹤0.01% | 2042 |
|
|
2019
Q3 | $8.21M | Buy |
357,527
+78,068
| +28% | +$1.67M | ﹤0.01% | 2331 |
|
|
2019
Q2 | $5.5M | Sell |
279,459
-29,032
| -9% | -$566K | ﹤0.01% | 2824 |
|
|
2019
Q1 | $6.01M | Sell |
308,491
-753,014
| -71% | -$14.3M | ﹤0.01% | 2535 |
|
|
2018
Q4 | $17.5M | Buy |
1,061,505
+330,171
| +45% | +$6.65M | 0.01% | 1577 |
|
|
2018
Q3 | $16.9M | Sell |
731,334
-27,603
| -4% | -$625K | ﹤0.01% | 1842 |
|
|
2018
Q2 | $16.5M | Sell |
758,937
-97,902
| -11% | -$1.91M | ﹤0.01% | 1834 |
|
|
2018
Q1 | $15.1M | Sell |
856,839
-109,025
| -11% | -$1.92M | ﹤0.01% | 1941 |
|
|
2017
Q4 | $18.1M | Sell |
965,864
-36,608
| -4% | -$728K | 0.01% | 1756 |
|
|
2017
Q3 | $22M | Buy |
1,002,472
+836,555
| +504% | +$18.9M | 0.01% | 1498 |
|
|
2017
Q2 | $4M | Buy |
165,917
+22,988
| +16% | +$585K | ﹤0.01% | 3100 |
|
|
2017
Q1 | $3.99M | Sell |
142,929
-107,409
| -43% | -$2.82M | ﹤0.01% | 3102 |
|
|
2016
Q4 | $6.11M | Sell |
250,338
-35,554
| -12% | -$815K | ﹤0.01% | 2783 |
|
|
2016
Q3 | $7.2M | Sell |
285,892
-76,174
| -21% | -$1.82M | ﹤0.01% | 2313 |
|
|
2016
Q2 | $7.47M | Buy |
362,066
+47,955
| +15% | +$1,000K | ﹤0.01% | 2233 |
|
|
2016
Q1 | $6.31M | Buy |
314,111
+258,212
| +462% | +$4.95M | ﹤0.01% | 2300 |
|
|
2015
Q4 | $1.13M | Buy |
55,899
+495
| +0.9% | +$10.4K | ﹤0.01% | 3966 |
|
|
2015
Q3 | $1.28M | Sell |
55,404
-6,461
| -10% | -$165K | ﹤0.01% | 3899 |
|
|
2015
Q2 | $1.59M | Sell |
61,865
-18,017
| -23% | -$512K | ﹤0.01% | 3819 |
|
|
2015
Q1 | $2.65M | Sell |
79,882
-41,632
| -34% | -$1.35M | ﹤0.01% | 3323 |
|
|
2014
Q4 | $3.69M | Sell |
121,514
-693,471
| -85% | -$19.1M | ﹤0.01% | 3010 |
|
|
2014
Q3 | $19.8M | Buy |
814,985
+445,359
| +120% | +$12.4M | 0.01% | 1446 |
|
|
2014
Q2 | $10.6M | Buy |
369,626
+210,372
| +132% | +$6.11M | ﹤0.01% | 1987 |
|
|
2014
Q1 | $4.44M | Buy |
159,254
+36,099
| +29% | +$992K | ﹤0.01% | 2689 |
|
|
2013
Q4 | $3.22M | Sell |
123,155
-67,677
| -35% | -$1.74M | ﹤0.01% | 2985 |
|
|
2013
Q3 | $4.39M | Sell |
190,832
-8,909
| -4% | -$220K | ﹤0.01% | 2561 |
|
|
2013
Q2 | $5.21M | Buy |
+199,741
| New | +$5.76M | ﹤0.01% | 2284 |
|
Other funds holding SBRA
VPM
VCM
N
Morgan Stanley's SBRA Position: Q1 2026 in Review
Morgan Stanley reduced its Sabra Healthcare REIT (SBRA) stake by 5.2% in Q1 2026, selling an estimated $2.4M and leaving 2,242,243 shares worth $43.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.
Morgan Stanley first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.9M in Q4 2023. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Morgan Stanley held 2,242,243 shares of Sabra Healthcare REIT worth $43.1M as of Q1 2026.
- Morgan Stanley sold 121,859 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.4M.
- Sabra Healthcare REIT made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2253 holding.
- Morgan Stanley first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Sabra Healthcare REIT position peaked at $57.9M in Q4 2023.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.